Researchers at University of California San Diego have identified a previously unrecognized treatment target for triple‑negative breast cancer...

Survival rates for many cancers have improved due to new treatments and earlier detection. Yet cases of some cancers, such as breast, prostate and...

Survival rates for many cancers have improved due to new treatments and earlier detection. Yet cases of some cancers, such as breast, prostate and...

A new therapeutic approach may help patients with bmedlinkacute myeloid leukemia/medlink/b respond better to standard treatment. Researchers...

A new therapeutic approach may help patients with bmedlinkacute myeloid leukemia/medlink/b respond better to standard treatment. Researchers...

MINNEAPOLIS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted...

MINNEAPOLIS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking oestrogen, progesterone, and HER2 receptors and thus...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking oestrogen, progesterone, and HER2 receptors and thus...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study systematically maps the...